Parry Nutraceuticals, Valensa expand microalgae plans through joint venture with Synthite Industries

摘要

Florida-based Valensa International has announced a joint venture agreement between Valensa's parent company EID Parry and Synthite Industries Ltd., which expands Valensa's plans to lead the development and distribution of value-added microalgae extracts for nutraceutical applications. The agreement includes a $6.5 million investment to establish a new plant for the extraction of Parry Organic Spirulina to produce Phycocyanin, which Valensa will be developing for dietary supplements, functional and medical foods.